Enterprise Imaging Viewer Receives Clearance for Additional Apps
By MedImaging International staff writers Posted on 15 Aug 2017 |
Image: Advanced clinical applications in use on the XERO universal viewer (Photo courtesy of Agfa Healthcare).
A major medical hardware and software provider has received US FDA 510(k) clearance for additional functionalities on its enterprise imaging zero-footprint viewer.
The viewer merges patient images and data from different departments and various sources in a hospital. Clinicians inside and outside a hospital, who satisfy the security policies and have the appropriate access rights, can now use the viewer to access the Digital Imaging and Communications in Medicine (DICOM) and non-DICOM imaging data in a single consolidated view.
The US FDA approval includes Xtend 3D processing and advanced clinical applications functionality on the Agfa Healthcare (Mortsel, Belgium) XERO Viewer. The functionality is now cleared for diagnostic viewing on desktop devices.
The approved advanced clinical applications on the browser-agnostic XERO Viewer now include Maximum Intensity Projection (MIP), MultiPlanar Reconstruction (MPR), mammography, orthopedics, nuclear medicine, and 3D visualization. In addition, iPad mobile diagnostic review and analysis now includes reports and ECG images.
The viewer can display images from either the Agfa HealthCare Enterprise Imaging IT platform, third-party Vendor Neutral Archives (VNA), or Picture Archiving and Communication Systems (PACS) in a single screen.
President of Imaging IT Solutions, Agfa HealthCare, James Jay, said, "We focus our continuous improvement efforts on meeting specific and real needs of healthcare providers; the features included in XERO Xtend fit that criterion. XERO, and the XERO Xtend feature set, help the healthcare enterprises to provide anywhere, anytime image access complete with powerful, useful image processing functions. The FDA 510(k) clearance for XERO Xtend supports our continued march forward."
The viewer merges patient images and data from different departments and various sources in a hospital. Clinicians inside and outside a hospital, who satisfy the security policies and have the appropriate access rights, can now use the viewer to access the Digital Imaging and Communications in Medicine (DICOM) and non-DICOM imaging data in a single consolidated view.
The US FDA approval includes Xtend 3D processing and advanced clinical applications functionality on the Agfa Healthcare (Mortsel, Belgium) XERO Viewer. The functionality is now cleared for diagnostic viewing on desktop devices.
The approved advanced clinical applications on the browser-agnostic XERO Viewer now include Maximum Intensity Projection (MIP), MultiPlanar Reconstruction (MPR), mammography, orthopedics, nuclear medicine, and 3D visualization. In addition, iPad mobile diagnostic review and analysis now includes reports and ECG images.
The viewer can display images from either the Agfa HealthCare Enterprise Imaging IT platform, third-party Vendor Neutral Archives (VNA), or Picture Archiving and Communication Systems (PACS) in a single screen.
President of Imaging IT Solutions, Agfa HealthCare, James Jay, said, "We focus our continuous improvement efforts on meeting specific and real needs of healthcare providers; the features included in XERO Xtend fit that criterion. XERO, and the XERO Xtend feature set, help the healthcare enterprises to provide anywhere, anytime image access complete with powerful, useful image processing functions. The FDA 510(k) clearance for XERO Xtend supports our continued march forward."
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow